Reduction membrane fluidity human breast cancer cells tamoxifen beta-estradiol intracellular steady-state levels methotrexate estrogen receptor ER human breast cancer cells ER-positive human breast cancer cells treatment relevant concentrations beta-estradiol tamoxifen TMX fluidity cellular membranes TMX concentrations microM perturbations membrane fluidity non-ER-mediated cytotoxicity Alterations membrane structure cytotoxicity high-dose endocrine therapy ability methotrexate transport cytotoxicity human breast cancer cells 